Anti-hemorrhagic of Dual Effect Hemostatic Platelet with Antifibrinolytic FactorTablet Oral
Each tablet contains: Etamsylate 250 mg, Tranexamic acid 250 mg, excipients q.s.ad 1 tablet
Coadjuvant in the treatment and control of hemorrhages. Control of hemostasis in traumatic, surgical, pathological processes and obstetric manipulations. Pre, trans and post-surgical haemorrhagic prophylaxis. In accidental traumatology, control of dysfunctional uterine bleeding, coadjuvant in the treatment of coagulation disorders and prevention of small blood vessel hemorrhages, hematuria (not of renal origin), melena, hematemesis, epistaxis, parvovirosis, auriculohematomas, caudotomy, auriculotomy, metrograms, elitrorragias, oncotomies, NSAID poisoning, gastric and duodenal ulcer perforation, traumatic peritonitis, ecchymosis, purpura, post-surgical hemorrhages, among others. Control of hyperfibrinolysis associated with infection by Angiostrongylus vasorum.
SENASA Registry: SENASA Peru: F.C2.31.I.0001